• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Membragel

Anonymous

Guest
A number of years ago, Straumann thought the global market potential for Membragel was approximately $200,000,000 annually. What type of annual sales are being generated?
 








Pretty ironic that this "respected" implant company has now invested more into cheap crappy foreign knockoff companies that in developing their own products to return to their once prestigious role in the industry.

They shut down their own biologics division to fund this crap?

Thats a lot of cash!

Apparently "value pricing" is more important than real value to Straumann

http://www.straumann.com/en/home/me...tag_xml_newsbox_ch2014-03-31149927digest.html

http://www.straumann.com/en/home/me...tag_xml_newsbox_ch2014-03-31149927digest.html

http://www.straumann.com/en/home/me...tag_xml_newsbox_ch2012-05-16149446digest.html
 








Read between the lines Straumann users. 3 major investments in "value implants", working deals with Patterson with discount implant lines... starting to get a clear picture?

It's only time until your ITI is filled with GPs buying $75 implants!